RADIATION THERAPY ONCOLOGY GROUP
RTOG 0415
A PHASE III RANDOMIZED STUDY OF HYPOFRACTIONATED 3D-CRT/IMRT VERSUS CONVENTIONALLY FRACTIONATED 3D-CRT/IMRT IN PATIENTS WITH FAVORABLE-RISK PROSTATE CANCER
RTOG 0415
A PHASE III RANDOMIZED STUDY OF HYPOFRACTIONATED 3D-CRT/IMRT VERSUS CONVENTIONALLY FRACTIONATED 3D-CRT/IMRT IN PATIENTS WITH FAVORABLE-RISK PROSTATE CANCER
Protocol Participation Information
- Credentialing
- Credentialing Requirements
- Dry Run Guidelines - please contact Bill Straube at (314) 362-9762 for details
- Facility Questionnaire: Part I and Part II are required for this protocol.
-
RPC Phantom Dosimetry Test (Prostate Phantom)
- Fill out the RPC Phantom Request Form to request shipment of a phantom.
- Contact Bill Straube at (314) 362-9762 regarding submission of phantom treatment planning data to the ITC.
- How to Participate
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- Submission Check list
- ATC Compliant Treatment Planning Systems
- Structure Names
- Contouring Examples (same as RTOG 0126)
- Protocol Text (http://www.rtog.org/)
Back to protocols
